October 17, 2024
TOPLINE: In patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) was associated with better urinary continence and sexual function, but slightly worse bowel function, compared […]
October 17, 2024
Romania faces significant challenges in cancer care, with high cancer mortality rates and limited access to comprehensive screening and treatment programs. “We desperately need to improve,” […]
October 17, 2024
TOPLINE: Induction chemotherapy followed by chemoradiotherapy improves 5-year overall survival rates in advanced cervical cancer from 72% to 80%. The treatment also enhances 5-year progression-free survival […]
October 16, 2024
TOPLINE: Five-fraction stereotactic body radiotherapy (SBRT) was found to be noninferior to conventionally or moderately hypofractionated radiotherapy in treating localized prostate cancer, with a 5-year freedom […]
October 16, 2024
It was Christmas time when Heloisa Soares, MD, shuffled through a family crowding her 68-year-old patient’s hospital bed. The prognosis wasn’t good. Soares, a GI cancer […]
October 15, 2024
TOPLINE: About one third of adult survivors of childhood cancer experience a clinically significant or high fear that their primary cancer may recur or that they […]
October 14, 2024
WASHINGTON — Proton craniospinal irradiation (CSI) may mark a new standard of care for treating leptomeningeal metastases, a rare but devastating complication of cancer, according to […]
October 11, 2024
The US Food and Drug Administration (FDA) has approved Hympavzi (marstacimab, Pfizer) as routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients […]
October 11, 2024
TOPLINE: Testing for mismatch repair (MMR) and microsatellite instability (MSI) among patients with colorectal cancer (CRC) increased from 22.7% in 2012 to 71.5% in 2021, but […]